Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 1958 entries
View as:

A Phase 1b Trial in Patients With Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01258348 Org: User:
Start: 07/31/08 End: 02/29/12 Due: 02/28/13

Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00191802 Org: User:
Start: 09/30/03 End: 10/31/05 Due: 10/31/06

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT01606748 Org: User:
Start: 08/31/12 End: 06/30/16 Due: 06/30/17

A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01925157 Org: User:
Start: 08/31/13 End: 09/30/15 Due: 09/30/16

A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia

Phase: N/A Priority: Normal
NCT ID: NCT05609825 Org: User:
Start: 11/14/22 End: 01/10/24 Due: 01/10/25

Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00267020 Org: User:
Start: 12/31/05 End: 05/31/08 Due: 05/31/09

A Study of Mirikizumab (LY3074828) Injection in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03053622 Org: User:
Start: 04/24/17 End: 04/03/18 Due: 04/03/19

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00094549 Org: User:
Start: 10/31/04 End: 12/31/06 Due: 12/31/07

The Cymbalta Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT01074151 Org: User:
Start: 07/31/09 End: 07/26/21 Due: 07/26/22

A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06916091 Org: User:
Start: 04/21/25 End: 08/31/25 Due: 08/31/26

Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)

Phase: N/A Priority: Normal
NCT ID: NCT00386425 Org: User:
Start: 11/30/06 End: 08/31/09 Due: 08/31/10

A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04188548 Org: User:
Start: 12/10/19 End: 12/31/27 Due: 12/31/28

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)

Phase: N/A Priority: Normal
NCT ID: NCT05662332 Org: User:
Start: 01/14/23 End: 07/19/24 Due: 07/19/25

Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00451555 Org: User:
Start: 04/11/07 End: 10/18/18 Due: 10/18/19

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

Phase: N/A Priority: Normal
NCT ID: NCT01148498 Org: User:
Start: 08/31/10 End: 08/31/12 Due: 08/31/13

Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00386087 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00035061 Org: User:
Start: - End: - Due: -

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02082210 Org: User:
Start: 03/07/14 End: 01/24/18 Due: 01/24/19

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT03616912 Org: User:
Start: 08/02/18 End: 03/09/22 Due: 03/09/23

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00079924 Org: User:
Start: 11/30/04 End: 05/31/07 Due: 05/31/08

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01997411 Org: User:
Start: 11/30/13 End: 01/31/15 Due: 01/31/16

Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine

Phase: N/A Priority: Normal
NCT ID: NCT00485407 Org: User:
Start: 07/31/03 End: 06/30/05 Due: 06/30/06

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Phase: N/A Priority: Normal
NCT ID: NCT00887354 Org: User:
Start: 04/30/09 End: 08/31/15 Due: 08/31/16

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02981342 Org: User:
Start: 01/12/17 End: 11/09/18 Due: 11/09/19

A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00087711 Org: User:
Start: 07/31/04 End: 03/31/08 Due: 03/31/09